Accessibility settings

This paper is in the following e-collection/theme issue:

Infoveillance and Social Listening (332) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1997) Information Quality in Digital Media (421) Information Seeking, Information Needs (597) Pharmacovigilance (185) Obesity and Nutrition as Public Health Problem (452)

Published on in Vol 5 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/59767, first published .
Online Information About Side Effects and Safety Concerns of Semaglutide: Mixed Methods Study of YouTube Videos

Online Information About Side Effects and Safety Concerns of Semaglutide: Mixed Methods Study of YouTube Videos

Online Information About Side Effects and Safety Concerns of Semaglutide: Mixed Methods Study of YouTube Videos

Authors of this article:

Andy Wai Kan Yeung1 Author Orcid Image ;   Fabian Peter Hammerle2, 3 Author Orcid Image ;   Sybille Behrens2 Author Orcid Image ;   Maima Matin4 Author Orcid Image ;   Michel-Edwar Mickael4 Author Orcid Image ;   Olena Litvinova2, 5 Author Orcid Image ;   Emil D Parvanov2, 6 Author Orcid Image ;   Maria Kletecka-Pulker2, 7 Author Orcid Image ;   Atanas G Atanasov2, 4 Author Orcid Image
Article Authors Cited by (7) Tweetations Metrics

Journals

  1. Rušić D, Durdov T, Jadrijević I, Šešelja Perišin A, Leskur D, Božić J, Klusmeier M, Bukić J. Semaglutide in the Real World: Attitudes of the Population. Pharmacy 2025;13(5):128 View
  2. Wang Q, Ma S, Ma D, Wang C, Qi X, Liu S, Zhang L, Xiang R, Zhao D. Video in Chinese short video sharing platforms as a source of information on sleep disorders: A cross-sectional content analysis study. DIGITAL HEALTH 2026;12 View
  3. Omosun F, Young A. Miracle or misfortune? Analyzing Reddit users’ narratives about Ozempic medication for weight loss. Atlantic Journal of Communication 2026:1 View
  4. Song J, He X, Cui Z, Sun Y, Liu Y, Yu H, Li A, Jin M. Quality and reliability of semaglutide content on different Chinese short video platforms: a study focusing on side effects. Frontiers in Public Health 2026;14 View
  5. Wilson A, Chamberlin S, Dabbs W, Heidel R, Grabeel K. Readability and understandability of online patient education on semaglutide. Health Informatics Journal 2026;32(1) View
  6. Nowak K, Łupina K, Kalisz A, Ilkiewicz Ł, Janczura J. GLP-1 Receptor Agonists: Therapeutic Potential and Emerging Concerns. Current Pharmacology Reports 2026;12(1) View
  7. Williams T, Bilic-Curcic I, Hurley J, Mummareddy H, Cigrovski Berkovic M, Canecki Varzic S, Gradiser M. Readability of AI-Generated Patient Information on Glucagon-Like Peptide-1 Receptor Agonists. JMIR Bioinformatics and Biotechnology 2026;7:e90572 View